Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psychedelic drug action at dendrites is gated by behavioral state and serotonin receptorsbioRxiv · 2026-07-19Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurementPsychedelics · 2026-07-17Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-15Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.Unknown journal · 2026-07-08Caution in interpreting value-related change after psilocybin: Comment on Kerr-Gaffney et al. (2026).Journal of Psychopharmacology · 2026-07-06The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer.BMC Medicine · 2026-07-05Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case ReviewMexican Journal of Medical Research ICSA · 2026-07-04Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health SymptomsJournal of Drug Issues · 2026-06-30Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?British journal of pharmacology · 2026-06-30Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".PLoS ONE · 2026-06-29Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23Psychedelics and related compounds in cluster headache and migraine: a systematic review and meta-analysis v1Unknown journal · 2026-06-20Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United StatesJournal of Psychoactive Drugs · 2026-06-18Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-16A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy studyInternational Journal of Drug Policy · 2026-06-04Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-02Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapyNatural Product Research · 2026-06-01Psilocybin shows rapid relief for depression symptomsMental Health Weekly · 2026-05-28Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Unknown journal · 2026-05-28Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case reportFrontiers in Neuroscience · 2026-05-27Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometryJournal of Analytical Toxicology · 2026-05-26Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake RatsNeuroscience Bulletin · 2026-05-20Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-05-12Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11Trials, trips, and tribulations: pathways for implementing psychedelic therapy in IrelandThe International Journal of Neuropsychopharmacology · 2026-05-08Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot StudyClinicalTrials.gov · 2026-05-05Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBSGastrointestinal Endoscopy · 2026-04-30Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in ratsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-04-30Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoformsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-04-30SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-04-30Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening StudyRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-04-30Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physiciansTherapeutic Advances in Psychopharmacology · 2026-04-30Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal CortexhBiological Psychiatry · 2026-04-24“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use DisorderAmerican Journal of Neuroradiology · 2026-04-23Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han ratsScience Letters · 2026-04-16Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in ratsScience Letters · 2026-04-16Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe MushroomsScience Letters · 2026-04-16Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online surveyJournal of Psychedelic Studies · 2026-04-14Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-08Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic UseCommunity Mental Health Journal · 2026-03-31Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-29Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelicsEuropean Archives of Psychiatry and Clinical Neuroscience · 2026-03-27Psychedelic Experiences and Finitude in Serious Illness: A Qualitative SynthesisJournal of Pain and Symptom Management · 2026-03-26Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-03-17Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted TherapiesThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · 2026-03-15Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT)Journal of Psychoactive Drugs · 2026-03-15Psilocybin Trends in States That Decriminalized UseJAMA · 2026-03-11Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase developmentJournal of Drug Delivery Science and Technology · 2026-03-09Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic reviewAmerican Journal of Health-System Pharmacy · 2026-03-03Public attitudes diverge sharply on legal use of psychedelicsMental Health Weekly · 2026-03-01Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-02-28Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico EvidenceInstituto Politécnico do Porto · 2026-02-24Prospective real-world evidence of mental health outcomes following supervised psilocybin services within the Oregon state-regulated modelmedRxiv · 2026-02-17Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative reviewBMJ Supportive & Palliative Care · 2026-02-17Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological AnalysisQualitative Health Research · 2026-02-16Effects of cannabis and psychedelic use on cognitive, psychomotor, and driving performance: A review of recent literatureCurrent Opinion in Toxicology · 2026-02-06Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).Professional Psychology Research and Practice · 2026-01-31PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSIONInternational Journal of Innovative Technologies in Social Science · 2026-01-27The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-25Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25RAND: Microdosing surges as millions turned to psychedelics in 2025Mental Health Weekly · 2026-01-22Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.Open Access CRIS of the University of Bern · 2026-01-20Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted TherapyJAMA Network Open · 2026-01-20Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-01-18Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptomsJournal of Affective Disorders · 2026-01-18Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.Unknown journal · 2026-01-15Chemical Design and Pharmacokinetics Enable Precision Psychedelic TherapeuticsACS Medicinal Chemistry Letters · 2026-01-11Presence of 4-Hydroxy-N-methyl-N-ethyltryptamine in Commercially Available Products.Unknown journal · 2026-01-06Associations of Couples’ Psychedelic Use with Shared Reality and Relational Well-BeingJournal of Psychoactive Drugs · 2026-01-05Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic ReviewOpen Science Framework · 2025-12-31Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal ExtractJournal of the Brazilian Chemical Society · 2025-12-31Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal StudiesVCU Scholars Compass (Virginia Commonwealth University) · 2025-12-31Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and PsilocybinHuman Psychopharmacology Clinical and Experimental · 2025-12-31New Antidepressant Development in the Treatment of Depression.Unknown journal · 2025-12-31Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure RisksUnknown journal · 2025-12-28From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applicationsCreative Science · 2025-12-18Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine-DMT FormulationsACS Medicinal Chemistry Letters · 2025-12-15COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISUnknown journal · 2025-12-10Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in SwitzerlandmedRxiv · 2025-11-30A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress modelScientific Reports · 2025-11-25Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-11-21Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid rewardNature Communications · 2025-11-19Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic MushroomsACS Omega · 2025-11-09Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativitybioRxiv · 2025-11-06Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?Performance Enhancement & Health · 2025-10-31Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applicationsCaderno Pedagógico · 2025-10-30Psilocybin use in bipolar disorder: A comprehensive review.Unknown journal · 2025-10-30Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticityBiomedicine & Pharmacotherapy · 2025-10-29Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.UNC Libraries · 2025-10-08Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.Nature · 2025-09-30Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley ratsJournal of Psychopharmacology · 2025-09-21Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the USJournal of Clinical Medicine · 2025-09-18Integrating Holistic Communication into Psychedelic-Assisted Therapies in Hospice and Palliative Care: An Approach Based on Peplau's TheoryJournal of Holistic Nursing · 2025-09-02PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCHInternational Journal of Innovative Technologies in Social Science · 2025-08-31A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31Psilocybin Use in the Autism Spectrum Disorder: A Scoping ReviewClinical Neuropharmacology · 2025-08-31Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trialTherapeutic Advances in Psychopharmacology · 2025-08-31Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybinMolecular Psychiatry · 2025-08-25Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resourcemedRxiv · 2025-08-15Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.Unknown journal · 2025-08-06Psilocybin-assisted treatment of depressionMedical Science · 2025-07-29Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trialAddiction · 2025-07-23“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smokeAddiction Science & Clinical Practice · 2025-07-20Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelicsJournal of Psychopharmacology · 2025-07-10Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.Unknown journal · 2025-07-09Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain modelsbioRxiv · 2025-07-06Psychedelic and Medicinal Mushrooms: Potent Source of Active Metabolites and MedicinesCurrent Bioactive Compounds · 2025-07-01Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-06-30Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autismMagna Scientia Advanced Research and Reviews · 2025-06-27The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.Unknown journal · 2025-06-23Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.Unknown journal · 2025-06-07Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.Unknown journal · 2025-06-05Mystical States & Psilocybin. From Dissociation Towards Association: A Conversational Model DiscussionThe Therapeutic Conversation · 2025-05-30Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical PopulationmedRxiv · 2025-05-28Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography-tandem mass spectrometryJournal of Analytical Toxicology · 2025-05-22Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?Unknown journal · 2025-05-18Serotonergic psychedelics for depression: A comprehensive overview.Unknown journal · 2025-05-13FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogsJournal of Pharmacological and Toxicological Methods · 2025-04-30The phenomenology of psilocybin: transformative insights for research and clinical practiceFrontiers in Psychology · 2025-04-24[Treatment with psychedelics: potential benefits in Parkinson's disease].PubMed · 2025-04-22Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Unknown journal · 2025-04-21The Rise of Psilocybin Use in the United States: A Multisource Observational StudyAnnals of Internal Medicine · 2025-04-20Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamusJournal of Psychopharmacology · 2025-04-1613. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-08Therapeutic Potential of Psilocybin-Assisted Therapy in Hospice and Palliative CareRevista Cacto - Ciência Arte Comunicação em Transdisciplinaridade Online · 2025-04-02Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.Unknown journal · 2025-04-01Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptorsNature · 2025-04-01Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disordersEuropean Psychiatry · 2025-03-31Pharmacokinetics of Psilocybin: A Systematic Review.Unknown journal · 2025-03-24Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24Lifetime classic psychedelic use and headaches: A cross-sectional studyJournal of Psychopharmacology · 2025-03-11Development and validation of a HPLC-DAD method for determining the content of tryptamines in methanolic extracts of fruiting bodies of mushrooms belonging to species of the Psilocybe genus.Unknown journal · 2025-02-20Psychedelics and Suicide-Related Outcomes: A Systematic Review.Unknown journal · 2025-02-19Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted PsychotherapyPolymatheia. · 2025-02-14Development of Psilocybe Mushroom Species Reference Material-Cultivation Parameters and Chemical ProfilesJournal of AOAC International · 2025-02-12Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake ratsbioRxiv · 2025-02-05The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.Unknown journal · 2025-02-05Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular BiologybioRxiv · 2025-02-05Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-reportJournal of Parkinson s Disease · 2025-02-01Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31DETERMINATION OF TRYPTAMINE ALKALOIDS AND THEIR STABILITY IN PSYCHOTROPIC MUSHROOMSThe International Journal of Neuropsychopharmacology · 2025-01-31Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.Expert review of neurotherapeutics · 2025-01-31Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Unknown journal · 2025-01-29Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28Effects of Psilocybin on Mouse Brain MicrostructureAmerican Journal of Neuroradiology · 2025-01-28Study finds encouraging results in psilocybin treatment for TRD patientsMental Health Weekly · 2025-01-09PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERSHealth and Society · 2025-01-07Additional file 1 of “I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smokeFigshare · 2024-12-31Political Attitudes towards the Legalization of Cannabis and PsilocybinSSRN Electronic Journal · 2024-12-31Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell ModelRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2024-12-31Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.Unknown journal · 2024-12-31The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.Therapeutic advances in psychopharmacology · 2024-12-31Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent mannerNeuropharmacology · 2024-12-23Characterizing psilocybin as an antidepressant for adolescence in male and female ratsbioRxiv · 2024-12-21ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.Unknown journal · 2024-12-09Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.Unknown journal · 2024-12-02Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-03Pyramidal cell types and 5-HT2A receptors are essential for psilocybin’s lasting drug actionbioRxiv · 2024-11-02Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experienceBJPsych Open · 2024-10-31Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical modelsBrain Behavior and Immunity · 2024-10-31Phytochemical screening, phenolic and flavonoid contents, psilocybin, antioxidant, and acetylcholinesterase inhibition activities of the aqueous extract from the fungi Cyathus striatus, Laternea dringii, and Marasmius haematocephalusBrazilian Journal of Science · 2024-10-31Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experienceBJPsych Open · 2024-10-31Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.Unknown journal · 2024-09-29Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.Unknown journal · 2024-09-29Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreatJournal of Psychopharmacology · 2024-09-26Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativityResearch Square · 2024-09-25B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-11Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.Pharmacological research · 2024-08-31Refractory CRPS pain treated with psilocybin: A case reportClinical Case Reports · 2024-08-31Psilocybin in pharmacotherapy of obsessive-compulsive disorder.Unknown journal · 2024-07-31Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry methodJournal of Chromatography A · 2024-07-03Effects of psilocybin on body weight, body composition, and metabolites in male and female micePhysiology & Behavior · 2024-07-01Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-06-30The Black Book of Psychotropic Dosing and Monitoring.Unknown journal · 2024-06-30Commentary on Darkeet al.: Expanded psychedelic access requires new safety monitoring systemsAddiction · 2024-06-16Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMAPsyArXiv · 2024-06-06THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Is it now time to prepare psychiatry for a psychedelic future?The British Journal of Psychiatry · 2024-05-19The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hydroxy-N,N-dimethyltryptamine)Acta Crystallographica Section E Crystallographic Communications · 2024-05-13The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodentsbioRxiv · 2024-04-21A dual-receptor model of serotonergic psychedelicsbioRxiv · 2024-04-14Psychedelic therapists, pharma collaborate on clinical trialMental Health Weekly · 2024-04-12Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and SafetyJAMA Psychiatry · 2024-04-09Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptoriScience · 2024-04-08Impact of Psilocybin on Peripheral Cytokine ProductionPsychedelic Medicine · 2024-02-27Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivityJournal of Affective Disorders · 2024-02-26Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a DecadeJournal of Adolescent Health · 2024-02-25